title: [Memory-enhancing drugs].
authors.forename: Tatsuhiro
authors.initials: T
authors.lastname: Akaishi
mesh_terms: D000818:Animals; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017362:Cyclic AMP Response Element-Binding Protein; D000077265:Donepezil; D055808:Drug Discovery; D048049:Extracellular Signal-Regulated MAP Kinases; D005702:Galantamine; D006624:Hippocampus / Q000503:physiopathology; D006801:Humans; D007189:Indans; D017774:Long-Term Potentiation / Q000187:drug effects / Q000502:physiology; D008559:Memantine; D008568:Memory / Q000187:drug effects*; D008569:Memory Disorders / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D058990:Molecular Targeted Therapy; D018697:Nootropic Agents / Q000494:pharmacology / Q000627:therapeutic use; D048448:Phenylcarbamates; D010880:Piperidines; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D000068836:Rivastigmine; D009435:Synaptic Transmission
chemical_list: D017362:Cyclic AMP Response Element-Binding Protein; D007189:Indans; D018697:Nootropic Agents; D048448:Phenylcarbamates; D010880:Piperidines; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D005702:Galantamine; D000077265:Donepezil; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D048049:Extracellular Signal-Regulated MAP Kinases; D000068836:Rivastigmine; D008559:Memantine